Sanofi · 5 days ago
Senior Associate Scientist, Retinal Degeneration
Cambridge, MA
Full-time
Onsite
Mid, Senior Level
4+ years expSanofi is an innovative global healthcare company dedicated to improving people’s lives through science. They are seeking a highly motivated Senior Associate Scientist to conduct preclinical drug discovery research for retinal diseases, focusing on validating therapeutic strategies and discovering drug candidates. This role involves collaboration in cross-functional teams to generate data that advances therapeutic candidates toward clinical development.
Health CareLife SciencePharmaceuticalTherapeutics
Responsibilities
Design, execute, and document translational research studies to validate therapeutic targets and discover preclinical drug candidates
Apply molecular, biochemical, and cellular assays to models of retinal disease and degeneration to assess disease processes, target activity, and biomarkers
Perform experiments using genetic, biologic, and small molecule perturbations to validate targets, evaluate therapeutic strategies, and assess the pharmacology and efficacy of preclinical candidates
Analyze and interpret experimental data to support target prioritization, preclinical candidate selection, and go/no-go decisions
Contribute to interdisciplinary research projects in a highly collaborative and matrixed manner
Prepare high-quality presentations and documentation to support project deliverables, publications, patent filings, and regulatory filings
Effectively communicate findings through presentation at team and department meetings
Qualification
Required
Earned Bachelor's degree plus minimum 4 years of relevant experience in an academic or biopharmaceutical setting or Master's Degree plus minimum 1 year relevant experience in an academic or biopharmaceutical setting
Research experience in ocular cell biology (e.g., RPE, RGC) or disease-relevant processes (e.g., cell death, metabolic and oxidative stress, lipid metabolism, tissue remodeling, barrier function, inflammatory signaling)
Experience in translational research or preclinical drug development (in vitro experience highly preferred)
Experience with molecular, cellular, and biochemical methods and assay development
Cell culture experience, including work with primary cells, iPSC-derived cells, tissue explants, or cell models relevant to ocular biology
Experience with genetic or pharmacologic approaches to assess gene and protein function, signaling pathway activity, and/or cellular processes
Experience preparing high-quality documents including experimental protocols, SOPs, technical reports, and presentations
Track record of contributions to research projects
Preferred
Experience analyzing data using computational and statistical tools (e.g., R, Python)
Experience in translational or preclinical drug development for retinal diseases
Experience evaluating target engagement and efficacy of preclinical candidates
Experience developing and conducting high-throughput assays
Experience with cell-based models of retinal disease and degeneration, including primary and iPSC-derived cells
Experience with live-cell and high-content imaging and analyses
Benefits
High-quality healthcare
Prevention and wellness programs
At least 14 weeks’ gender-neutral parental leave
Company
Sanofi
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
10001+ employees
H1B Sponsorship
Sanofi has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (101)
2024 (68)
2023 (59)
2022 (78)
2021 (38)
2020 (38)
Funding
Current Stage
Public CompanyTotal Funding
$6.97BKey Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B
Leadership Team
Paul Hudson
Chief Executive Officer
Francois-Xavier Roger
Chief Financial Officer
Recent News
Company data provided by crunchbase